GTC Biotherapeutics
North America, Massachusetts, United States, Framingham
Description
GTC Biotherapeutics is a developer of human therapeutic proteins in the milk of transgenic animals.
Investor Profile
GTC Biotherapeutics has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series C (100%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
